Partial splenectomy before a hematopoietic stem cell transplantation in children

被引:9
|
作者
Hall, JG
Kurtzberg, J
Szabolcs, P
Skinner, MA
Rice, HE
机构
[1] Duke Univ, Med Ctr, Dept Surg, Div Pediat Surg, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Pediat Bone Marrow & Stem Cell Transplant Program, Durham, NC 27710 USA
关键词
partial splenectomy; hematopoietic stem cell transplantation; engraftment; VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; MYELOFIBROSIS; SEVERITY; LEUKEMIA; SPLEEN;
D O I
10.1016/j.jpedsurg.2004.09.047
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Hematopoietic stem cell (HSC) engraftment is delayed in children with hypersplenism, and splenectomy may improve HSC engraftment. However, the use of total splenectomy in children is limited because of concerns for postsplenectomy sepsis. In this study, the authors sought to assess the role of partial splenectomy for children with hypersplenism undergoing HSC transplantation. Methods: Five children with a variety of conditions and associated hypersplenism underwent partial splenectomy before an HSC transplantation at the authors' institution between 2000 and 2003. Primary outcome measures were rates of neutrophil and platelet engraftment. Secondary outcome measures included perioperative complications, splenic regrowth, graft-versus-host disease, and infection rate. All outcomes were compared with recipients of an HSC transplant from both age-matched nonsplenectomized children (n = 497) and hypersplenic children who underwent total splenectomy (n = 10). Outcomes were compared using Wilcoxon's rank sum test. Results: The rate of both neutrophil and platelet engraftment was faster in children who underwent either partial or total splenectomy as compared with nonsplenectomized children (mean rates of neutrophil engraftment were 26, 19, and 19 days for the nonsplenectomy, total splenectomy, and partial splenectomy groups, respectively; mean rates of platelet engraftment were 97, 37, and 45 days for the nonsplenectomy, total splenectomy, and partial splenectomy groups, respectively). Graft-versus-host disease rates were similar between the 3 groups. The mean percentage of splenic regrowth after partial splenectomy was 39%. There were no perioperative complications. Conclusions: Partial splenectomy may be safely performed before HSC transplantation and, similar to total splenectomy, may improve the rate of HSC engraftment. Although this series has a limited number of patients, the use of partial splenectomy appears to be safe and may allow for splenic salvage to minimize the risk of postsplenectomy sepsis. (C) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:221 / 227
页数:7
相关论文
共 50 条
  • [31] Cardiovascular Risk in Patients before and after Hematopoietic Stem Cell Transplantation
    Sossa, Claudia
    Ardila-Baez, Manuel
    Wandurraga, Edwin
    Serrano, Sergio
    Luna-Gonzalez, Maria
    Salazar, Luis A.
    Jimenez, Sara I.
    Rosales, Manuel
    Pena, Angela M.
    Chen, Xueyi
    Rey, Juan J.
    Chacon, Maria A.
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 426 - 427
  • [32] Mood states in adult patients before hematopoietic stem cell transplantation
    Fukuo, W
    Yoshiuchi, K
    Kikuchi, H
    Sakamoto, N
    Sasaki, T
    Nakahara, R
    Yamanaka, G
    Kanda, Y
    Chiba, S
    Hirai, H
    Kumano, H
    Kuboki, TF
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 2005, 58 (06) : S71 - S71
  • [33] Cardiac systolic function before and after hematopoietic stem cell transplantation
    Lehmann, S
    Isberg, B
    Ljungman, P
    Paul, C
    BONE MARROW TRANSPLANTATION, 2000, 26 (02) : 187 - 192
  • [34] Cardiac systolic function before and after hematopoietic stem cell transplantation
    S Lehmann
    B Isberg
    P Ljungman
    C Paul
    Bone Marrow Transplantation, 2000, 26 : 187 - 192
  • [35] Allogeneic hematopoietic stem cell transplantation in children with sickle cell disease
    Locatelli, Franco
    Pagliara, Daria
    PEDIATRIC BLOOD & CANCER, 2012, 59 (02) : 372 - 376
  • [36] Hematopoietic Stem Cell Transplantation in Children with Refractory Langerhans Cell Histiocytosis
    Kudo, Kazuko
    Maeda, Miho
    Suzuki, Nobuhiro
    Kanegane, Hirokazu
    Ohga, Shouichi
    Ishii, Eiichi
    Shioda, Yoko
    Imamura, Toshihiko
    Imashuku, Shinsaku
    Tsunematsu, Yukiko
    Endo, Mikiya
    Shimada, Akira
    Koga, Yuhki
    Hashii, Yoshiko
    Inagaki, Jiro
    Inoue, Masami
    Tabuchi, Ken
    Morimoto, Akira
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S35 - S35
  • [37] Hematopoietic Stem Cell Transplantation in Children with Refractory Langerhans Cell Histiocytosis
    Kudo, Kazuko
    Maeda, Miho
    Suzuki, Nobuhiro
    Kanegane, Hirokazu
    Ohga, Shouichi
    Ishii, Eiichi
    Shioda, Yoko
    Imamura, Toshihiko
    Imashuku, Shinsaku
    Tsunematsu, Yukiko
    Endo, Mikiya
    Shimada, Akira
    Koga, Yuuki
    Hashii, Yoshiko
    Inagaki, Jiro
    Inoue, Masami
    Tabuchi, Ken
    Morimoto, Akira
    BLOOD, 2018, 132
  • [38] Hematopoietic Stem Cell Transplantation in Children with Refractory Langerhans Cell Histiocytosis
    Kudo, Kazuko
    Maeda, Miho
    Suzuki, Nobuhiro
    Kanegane, Hirokazu
    Ohga, Shouichi
    Ishii, Eiichi
    Shioda, Yoko
    Imamura, Toshihiko
    Imashuku, Shinsaku
    Tsunematsu, Yukiko
    Endo, Mikiya
    Shimada, Akira
    Koga, Yuhki
    Hashii, Yoshiko
    Inagaki, Jiro
    Inoue, Masami
    Tabuchi, Ken
    Morimoto, Akira
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S19 - S20
  • [39] Hematopoietic Stem Cell Transplantation in Nigerian Children with Sickle Cell Anemia
    Isgro, Antonella
    Gaziev, Javid
    Sodani, Pietro
    Andreani, Marco
    Testi, Manuela
    Paciaroni, Katia
    Gallucci, Cristiano
    De Angelis, Gioia
    Marziali, Marco
    Alfieri, Cecilia
    Ribersani, Michela
    Akinyanju, Olufemi O.
    Wakama, T. Thompson
    Olowoselu, Festus Olusola
    Lucarelli, Guido
    BLOOD, 2015, 126 (23)
  • [40] Hematopoietic Stem Cell Transplantation in Nigerian Children with Sickle Cell Anemia
    Isgro, A.
    Gaziev, J.
    Sodani, P.
    Andreani, M.
    Testi, M.
    Paciaroni, K.
    Gallucci, C.
    De Angelis, G.
    Marziali, M.
    Alfieri, C.
    Ribersani, M.
    Akinyanju, O. O.
    Wakama, T. T.
    Olowoselu, F. O.
    Lucarelli, G.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S254 - S255